Institutional investors purchased a net $5.6 million shares of THRX during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 81.26% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
QUANTBOT TECHNOLOGIES LLC Bought 18.5 Thousand shares of Theravance Inc
LPL FINANCIAL LLC Bought 7.3 Thousand shares of Theravance Inc
PHARUS MANAGEMENT SA Bought 2.5 Thousand shares of Theravance Inc